Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000649094 | SCV000770919 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001756082 | SCV001997523 | uncertain significance | not provided | 2023-05-19 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV002325296 | SCV002609338 | uncertain significance | Cardiovascular phenotype | 2023-10-24 | criteria provided, single submitter | clinical testing | The p.P1070L variant (also known as c.3209C>T), located in coding exon 21 of the FLNC gene, results from a C to T substitution at nucleotide position 3209. The proline at codon 1070 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001756082 | SCV003831459 | uncertain significance | not provided | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003420137 | SCV004113792 | uncertain significance | FLNC-related disorder | 2023-03-28 | criteria provided, single submitter | clinical testing | The FLNC c.3209C>T variant is predicted to result in the amino acid substitution p.Pro1070Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-128484728-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486910 | SCV004240639 | uncertain significance | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing |